Description

Polymerase chain reaction (PCR) is a laboratory technique used to amplify DNA sequences. The technique can produce a billion copies of the target sequence in just a few hours. Once amplified, the DNA produced by PCR can be used in many different laboratory procedures. PCR is also valuable in a number of laboratory and clinical techniques, including DNA fingerprinting, detection of bacteria or viruses (particularly AIDS), and diagnosis of genetic disorders. The global polymerase chain reaction market is set to grow by US$ 3.86 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period, according to data and analytics company StrategyHelix. Rise in prevalence of infectious diseases and cancer, increase in awareness and acceptance of personalized medicines, rapid increase in geriatric population, rise in disposable income in developing economies are expected to boost the market growth in the coming years.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for polymerase chain reaction. The global polymerase chain reaction market is segmented on the basis of product, technology, application, and region. By product, it is categorized into reagents & consumables, instruments, software, and services. The reagents & consumables segment held the largest market share in 2020. By technology, the polymerase chain reaction market is divided into real-time PCR, inverse PCR, assembly & nested PCR, multiplex PCR, reverse transcriptase PCR, and others. Based on application, the polymerase chain reaction market is divided into research, clinical, and others.

The report has profiled some of the key players of the market such as Abbott Laboratories, Becton Dickinson and Company, BioFire Diagnostics LLC, Bio-Rad Laboratories Inc., Eppendorf AG, F. Hoffmann-La Roche AG, GE Healthcare, Hologic Inc., Merck KGaA (Sigma-Aldrich), QIAGEN N.V., Thermo Fisher Scientific Inc..

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the polymerase chain reaction market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: reagents & consumables, instruments, software, and services
Technology: real-time PCR, inverse PCR, assembly & nested PCR, multiplex PCR, reverse transcriptase PCR, and others
Application: research, clinical, and others
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders

Get a comprehensive picture of the global polymerase chain reaction market
Identify regional strategies and strategic priorities on the basis of local data and analysis
Pinpoint growth sectors and trends for investment
Understand what the future of the global polymerase chain reaction market looks like
Identify the competitive landscape and window of opportunity

Table of Contents

1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. Polymerase Chain Reaction Market by Product
4.1 Reagents & Consumables
4.2 Instruments
4.3 Software
4.4 Services
5. Polymerase Chain Reaction Market by Technology
5.1 Real-Time Pcr
5.2 Inverse Pcr
5.3 Assembly & Nested Pcr
5.4 Multiplex Pcr
5.5 Reverse Transcriptase Pcr
5.6 Others
6. Polymerase Chain Reaction Market by Application
6.1 Research
6.2 Clinical
6.3 Others
7. Polymerase Chain Reaction Market by Region
7.1 North America
7.2 Asia Pacific
7.3 Europe
7.4 Rest Of The World (Row)
8. Company Profiles
8.1 Abbott Laboratories
8.2 Becton, Dickinson and Company
8.3 BioFire Diagnostics LLC
8.4 Bio-Rad Laboratories Inc.
8.5 Eppendorf AG
8.6 F. Hoffmann-La Roche AG
8.7 GE Healthcare
8.8 Hologic Inc.
8.9 Merck KGaA (Sigma-Aldrich)
8.10 QIAGEN N.V.
8.11 Thermo Fisher Scientific Inc.
9. Appendix
9.1 About StrategyHelix
9.2 Disclaimer